{"id":"aminosalicylic-acid-hydrazide","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{"commonSideEffects":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"apacizin","offLabel":[],"synonyms":["aminosalicylic acid hydrazide","4-Aminosalicylic acid hydrazide","apacizin","apacizina","pasdrazide","p-aminosalicylic acid hydrazide"],"timeline":[],"brandName":"Apacizin","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine your body's cells are like a city, and the molecules inside those cells are like the traffic. Apacizin is like a traffic controller that helps regulate the flow of molecules to produce a specific effect. This can help to either slow down or speed up certain processes in the body, depending on the desired outcome.","oneSentence":"Apacizin works by interacting with specific biological molecules to produce its therapeutic effect.","technicalDetail":"Apacizin, as a small molecule, is likely to work by binding to specific receptors or enzymes, altering their activity and producing a downstream effect. However, without more information on its target and mechanism of action, it is difficult to provide a more detailed explanation."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/2051","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=aminosalicylic acid hydrazide","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T08:41:19.479607","biosimilars":[],"competitors":[],"genericName":"aminosalicylic acid hydrazide","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"ODX97PJ52T","CHEBI":"CHEBI:134800","PUBCHEM_CID":"72490"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":99,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Apacizin, also known as aminosalicylic acid hydrazide, is a small molecule drug with unknown target and drug class. Its commercial status is unclear, and it has not been approved by the FDA for any indications. As a small molecule, it is likely to work by interacting with specific biological molecules to produce its therapeutic effect. However, without more information, it is difficult to provide a comprehensive summary of its mechanism of action and safety considerations. Further research is needed to fully understand this compound.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}